跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-GLICLAZIDE MR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-GLICLAZIDE MR
Authorized
STANDARD
AG-GLICLAZIDE MR
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d3108c6d1b362ee5
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
d3108c6d1b362ee5
Drug Approval Canada Name
AG-GLICLAZIDE MR
Product Name
AG-GLICLAZIDE MR
Status
Marketed
Status Date
2025-02-03
Original Market Date
2025-02-03
Din
02483300
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.20
Atc Original
A10BB09 GLICLAZIDE
Atc Name
a 10 bb 09
Aig Number
0119934002
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
GLICLAZIDE
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d3108c6d1b362ee5
Type
Standard
Back to Health Canada Approvals